Ida Aronchik

Ida Aronchik has a diverse work experience spanning multiple roles and industries. Ida is currently working at REVOLUTION Medicines as a Senior Director of Translational Sciences since February 2023. Prior to this, they held the position of Director of Translational Sciences at the same company from July 2021. Previously, they worked at Bristol Myers Squibb as a Scientific Associate Director from January 2021 to June 2021. Ida also has a long tenure at Celgene, where they held various positions including Principal Scientist, Senior Scientist, Scientist II, and Scientist between December 2013 and January 2021. Before joining Celgene, they worked as a Postdoctoral Fellow at the Novartis Institutes for BioMedical Research from October 2011 to November 2013. Additionally, they served as a Postdoctoral Fellow at the Cancer Research Lab at UC Berkeley from July 2009 to March 2012 and as a Graduate Student in the Molecular Toxicology Ph.D. program from August 2004 to June 2009. Ida also gained experience as a Research Associate II at the Dermatology Research Department at the Northern California Institute for Research and Education from June 2001 to August 2004. Earlier in their career, they worked as a Research Assistant at the Environmental Microbiology Laboratories from 2000 to May 2001 and as an Undergraduate Student-Research Assistant at the Immunology Research Laboratory at San Francisco State University from 1999 to 2001.

Ida Aronchik completed their education at two renowned institutions. From 2004 to 2009, they attended the University of California, Berkeley, where they earned a Ph.D. in Molecular Toxicology. Prior to that, between 1999 and 2001, they obtained a Bachelor of Science degree in Microbiology from San Francisco State University.